What is Wavegate Corporation?
Wavegate Corporation is a medical technology company focused on advanced solutions for chronic pain management. Its flagship product, the EllipseTM Spinal Cord Stimulator Platform, utilizes proprietary StimuLuxTM Active LoopTM technology. This platform is designed to offer a more effective treatment option for individuals suffering from persistent pain, positioning Wavegate as an innovator in the neurostimulation sector.
How much funding has Wavegate Corporation raised?
Wavegate Corporation has raised a total of $26M across 1 funding round:
Series A
$26M
Series A (2024): $26M with participation from UCEA Capital Partners
Key Investors in Wavegate Corporation
UCEA Capital Partners
UCEA Capital Partners is a diversified single-family office with a broad investment strategy across healthcare, technology, and other sectors, focusing on direct and co-investment opportunities.
What's next for Wavegate Corporation?
With this substantial strategic investment, Wavegate Corporation is expected to accelerate its product development, enhance its market penetration, and potentially expand its clinical research initiatives. The major enterprise-level funding indicates strong investor confidence in the company's technology and its potential to capture a significant share of the pain management market. Future growth will likely involve scaling manufacturing, expanding sales and marketing efforts, and potentially exploring new therapeutic applications for its core technology.
See full Wavegate Corporation company page
